186 related articles for article (PubMed ID: 24244321)
1. Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.
Hao X; Liu X; Wang W; Ren H; Xie J; Shen P; Lin D; Chen N
PLoS One; 2013; 8(11):e78531. PubMed ID: 24244321
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
[TBL] [Abstract][Full Text] [Related]
3. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
Ramezani A; Devaney JM; Cohen S; Wing MR; Scott R; Knoblach S; Singhal R; Howard L; Kopp JB; Raj DS
Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967
[TBL] [Abstract][Full Text] [Related]
4. Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients.
Mbakop C; DeVita MV; Wahl SJ; Bijol V; Rosenstock JL
Int Urol Nephrol; 2021 Apr; 53(4):719-724. PubMed ID: 33200335
[TBL] [Abstract][Full Text] [Related]
5. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
6. Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.
Hasim A; Ma H; Mamtimin B; Abudula A; Niyaz M; Zhang LW; Anwer J; Sheyhidin I
Mol Biol Rep; 2012 Sep; 39(9):8955-64. PubMed ID: 22736106
[TBL] [Abstract][Full Text] [Related]
7.
Kalantari S; Nafar M; Samavat S; Parvin M; Nobakht M Gh BF; Barzi F
Magn Reson Chem; 2016 Oct; 54(10):821-826. PubMed ID: 27320161
[TBL] [Abstract][Full Text] [Related]
8. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
9. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
Erkan E; Zhao X; Setchell K; Devarajan P
Pediatr Nephrol; 2016 Apr; 31(4):581-8. PubMed ID: 26537928
[TBL] [Abstract][Full Text] [Related]
10. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome].
Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Agraz I; Salcedo MT
Nefrologia; 2014; 34(1):46-52. PubMed ID: 24463862
[TBL] [Abstract][Full Text] [Related]
12. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
[TBL] [Abstract][Full Text] [Related]
13. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study.
Haas M; Spargo BH; Coventry S
Am J Kidney Dis; 1995 Nov; 26(5):740-50. PubMed ID: 7485126
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Helmuth A; Huynh-Do U
Ther Umsch; 2015 Mar; 72(3):189-93. PubMed ID: 25722312
[TBL] [Abstract][Full Text] [Related]
15. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
[TBL] [Abstract][Full Text] [Related]
16. Potential urine proteomics biomarkers for primary nephrotic syndrome.
Choi YW; Kim YG; Song MY; Moon JY; Jeong KH; Lee TW; Ihm CG; Park KS; Lee SH
Clin Proteomics; 2017; 14():18. PubMed ID: 28522940
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study of anti-CD40 and ubiquitin proteasome antibodies in primary podocytopaties.
Chebotareva N; Cao V; Vinogradov A; Alentov I; Sergeeva N; Kononikhin A; Moiseev S
Front Med (Lausanne); 2023; 10():1189017. PubMed ID: 37409273
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
Deegens JK; Wetzels JF
Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
[TBL] [Abstract][Full Text] [Related]
19. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
20. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
